Work

Low plasma CC16 levels in smokers are associated with a higher risk for chronic bronchitis

Year: 2015

Type: article

Study design: Observational Study

Source: European Respiratory Journal

DOI: 10.1183/13993003.00682-2015

Authors: Hans Petersen, Shuguang Leng, Steven A. Belinsky, Bruce E. Miller, Ruth Tal-Singer, Caroline A. Owen, Bartolome Celli, Yohannes Tesfaigzi

Institutions: Lovelace Respiratory Research Institute, GlaxoSmithKline (United States), Brigham and Women's Hospital, Harvard University

Language: English

Topic: Chronic Obstructive Pulmonary Disease (COPD) Research

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: National Institutes of Health, National Heart, Lung, and Blood Institute, National Cancer Institute, National Institute of Allergy and Infectious Diseases, National Institute of Environmental Health Sciences

Awards: Factors for Epigenetic Silencing of Lung Cancer Genes, Targeting MMP9 to Improve Outcomes in Serious Influenza Infections, "Biomarker signature in COPD", G3775936536, G3842720522, G3969178597, Resolution of Epithelial Cell Hyperplasia, G4089291197, Functional Genetics of COPD, G6179329026, Epigenetic Changes Link COPD and Lung Cancer, Distinct and Overlapping Pathways of Fibrosis and Emphysema in Cigarette Smokers, Resolution of Epithelial Cell Hyperplasia in Asthma

OpenAlex ID: W1651452435

FWCI: 1.582

Cites: 14

Cited by: 24

Related to: 10